Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Neuregulin 1 and schizophrenia.

Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K.

Ann Med. 2004;36(1):62-71. Review.

PMID:
15000348
2.

Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

Harrison PJ, Law AJ.

Biol Psychiatry. 2006 Jul 15;60(2):132-40. Epub 2006 Jan 25. Review.

PMID:
16442083
3.

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.

Geddes AE, Huang XF, Newell KA.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):896-904. doi: 10.1016/j.pnpbp.2011.02.017. Epub 2011 Mar 1. Review.

PMID:
21371516
4.

Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.

Corfas G, Roy K, Buxbaum JD.

Nat Neurosci. 2004 Jun;7(6):575-80. Review.

PMID:
15162166
5.

Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?

Scolnick EM, Petryshen T, Sklar P.

Harv Rev Psychiatry. 2006 Mar-Apr;14(2):64-77. Review.

PMID:
16603473
6.

Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies.

Schmitt A, Parlapani E, Gruber O, Wobrock T, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2008 Nov;258 Suppl 5:35-9. doi: 10.1007/s00406-008-5019-x. Review.

PMID:
18985292
7.

[In search of susceptibility genes for schizophrenia].

Schosser A, Aschauer HN.

Wien Klin Wochenschr. 2004 Dec 30;116(24):827-33. Review. German.

PMID:
15690966
8.

Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.

Pan B, Huang XF, Deng C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):924-30. doi: 10.1016/j.pnpbp.2011.04.002. Epub 2011 Apr 13. Review.

PMID:
21513767
9.

Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):132-9. doi: 10.1016/j.brainresbull.2010.04.011. Epub 2010 Apr 28. Review.

PMID:
20433909
10.

NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia.

Ramsey AJ.

Prog Brain Res. 2009;179:51-8. doi: 10.1016/S0079-6123(09)17906-2. Epub 2009 Nov 20. Review.

PMID:
20302817
11.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Harrison PJ, Weinberger DR.

Mol Psychiatry. 2005 Jan;10(1):40-68; image 5. Review. Erratum in: Mol Psychiatry. 2005 Aug;10(8):804. Mol Psychiatry. 2005 Apr;10(4):420.

PMID:
15263907
12.

Association of the NRG1 gene and schizophrenia: a meta-analysis.

Munafò MR, Thiselton DL, Clark TG, Flint J.

Mol Psychiatry. 2006 Jun;11(6):539-46. Review. Erratum in: Mol Psychiatry. 2006 Jun;11(6):613.

PMID:
16520822
13.

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Mei L, Xiong WC.

Nat Rev Neurosci. 2008 Jun;9(6):437-52. doi: 10.1038/nrn2392. Epub 2008 May 14. Review.

14.

Schizophrenia: genes at last?

Owen MJ, Craddock N, O'Donovan MC.

Trends Genet. 2005 Sep;21(9):518-25. Review.

PMID:
16009449
15.

The genes for schizophrenia: finally a breakthrough?

Shirts BH, Nimgaonkar V.

Curr Psychiatry Rep. 2004 Aug;6(4):303-12. Review.

PMID:
15260947
16.

Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis.

Enomoto T, Noda Y, Nabeshima T.

Methods Find Exp Clin Pharmacol. 2007 May;29(4):291-301. Review.

PMID:
17609743
17.

Molecular biological investigations into the role of the NMDA receptor in the pathophysiology of schizophrenia.

Catts SV, Ward PB, Lloyd A, Huang XF, Dixon G, Chahl L, Harper C, Wakefield D.

Aust N Z J Psychiatry. 1997 Feb;31(1):17-26. Review.

PMID:
9088482
18.

Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.

O'Tuathaigh CM, Babovic D, O'Meara G, Clifford JJ, Croke DT, Waddington JL.

Neurosci Biobehav Rev. 2007;31(1):60-78. Epub 2006 Jun 19. Review.

PMID:
16782199
19.

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Muller N, Schwarz M.

Neurotox Res. 2006 Oct;10(2):131-48. Review.

PMID:
17062375
20.

Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Deng C, Pan B, Engel M, Huang XF.

Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7. Review.

PMID:
23389757
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk